Taiwan Medical Device Registration

Unlock the Taiwanese market with expert regulatory guidance, quality system oversight, and an independent Taiwan agent, with Cisema.

We help foreign manufacturers of Taiwan medical devices and IVDs in Taiwan successfully register their products with the Taiwan Food and Drug Administration (TFDA), meet all documentation and quality system documentation requirements, and maintain compliance across the device lifecycle. As your Taiwan Registration Holder (TRH), we manage your Taiwan medical device registration process from initial classification strategy through post-market surveillance.

With a presence in Taipei and a deep understanding of Taiwan’s Medical Devices Act, Cisema acts as your trusted in country regulatory representative. We provide complete support for device classification, technical reviews, quality system documentation QSD, and registration submission for Class I, Class II, and III devices.

Whether registering a new product, seeking amendments to your medical device permit license, or managing post-market obligations, Cisema gives you clarity, speed, and control.

From risk assessment and QMS alignment to TFDA application support and labeling compliance, we simplify your path to market. We also assist with documentation aligned to the Good Manufacturing Practice requirements and ISO 13485, ensuring conformity with Taiwan medical device expectations.

Taiwan Medical Device Registration
Medical Device Registration in Taiwan

Service for IVD & Medical Device Registration in Taiwan

Cisema’s team manages your full device registration in Taiwan, aligning with the Taiwan Food and Drug Administration authority’s requirements and supporting a seamless market entry.

Regulatory Strategy & Classification

Classify your Taiwan medical device or IVD under Taiwan’s risk-based framework (Class I, Class II, or Class III)
Determine whether fast-track or pre market approval based on reference countries is applicable
Define the most effective regulatory pathway according to your primary intended actions

Quality System Documentation (QSD) Registration

Before submitting your product registration application to TFDA, most manufacturers must obtain a Quality System Documentation (QSD) certificate. This mandatory step verifies your compliance with ISO 13485 or an equivalent quality management system. We guide you in preparing and submitting your full QSD application and managing all interactions with TFDA until your certificate is issued.

QSD is required for all Class II and III devices, and many Class I products
Some Class I non-sterile, non-measuring devices may be exempt
QSD approval is performed as a remote, paper-based review by the Taiwan Food and Drug authority
Documentation includes ISO 13485 certificate, SOPs, quality manual and facility details
QSD and product registration can be submitted in parallel, but TFDA will issue the medical device permit license only after QSD approval
Typical QSD review time is around 6 months and the certificate is valid for 3 years.

Registration Application & TFDA Submission

Submit through the TFDA e-Portal and manage all administrative and technical reviews
Act as your regulatory contact for communication with the TFDA
Localize Instructions for Use (IFU), packaging, and labeling to meet Taiwan Food and Drug Administration standards
Coordinate submission fees and respond to authority feedback throughout the pre market approval process.

Post-Approval Services

Handle renewals, reclassification, and amendments to the medical device permit license
Manage adverse event reporting, serious adverse event follow-up, and Field Safety Corrective Actions (FSCA) coordination.

Taiwan Agent & Taiwan Registration Holder Services

Foreign manufacturers must appoint a Taiwan agent or in country regulatory representative as the legal license holder to register with the Taiwan Food and Drug Administration. Cisema acts as your compliant TRH, fulfilling all regulatory duties transparently.

What we do:

Serve as your legal license holder for all Taiwan medical device, IVD and combined product registrations
Submit and maintain your product license with TFDA
Issue Letters of Authorization to your preferred importers and distributors
Enable flexibility in changing distributors without re-registration
Monitor post-market updates and ensure ensuring compliance with the Medical Devices Act
Manage direct prevention actions like FSCA and recalls
Maintain your quality system, and support audits and inspections tied to ISO 13485

Quality Control Inspection Services in Taiwan

Cisema also provides tailored inspection services for Taiwan medical devices and IVDs to ensure compliance with local and international standards.

Incoming Goods Inspections

Verify packaging, labeling, and shipping conditions upon arrival
Review documentation including invoices, certifications, and declarations of conformity
Confirm product readiness for the Taiwanese market

In-Process Quality Monitoring

Inspect during repackaging or relabeling for hygiene, SOPs, and quality system control
Validate traceability and batch consistency

Final Product Release Inspections

Conduct AQL sampling and performance checks
Ensure conformity of labeling and IFU with Taiwanese regulatory requirements

Special Inspection Projects

Support Good Manufacturing Practice audits and TFDA site inspections
Collaborate with third-party bodies for tailored compliance audits
Conduct serial number validation and corrective action reviews.

Why Work with Cisema?

Local expertise with global reach

Our bilingual teams bridge international quality standards with local regulations

Proven track record

Over 20 years supporting market approvals and compliance in China and Asia Pacific

End-to-end solutions

From system setup to post-market surveillance, we ensure quality management and regulatory compliance throughout the product lifecycle

Industry breadth

Cross-sector expertise in life sciences, food, veterinary, consumer and industrial goods

Role of a China Agent

Useful Articles

View More

Digital Medical Device Clinical Trials in South Korea: Understanding the MFDS Framework

Understand MFDS clinical trial requirements for digital medical devices, including real-world evidence, data-based studies, and software validation expectations.

June 2, 2026
Digital Medical Device Clinical Trials in South Korea: Understanding the MFDS Framework

Cisema Expands into South Korea

Supporting foreign manufacturers entering South Korea with regulatory services for medical devices, IVDs, and quasi-drugs.

June 1, 2026
Cisema Expands into South Korea
Seoul skyline in the early evening

Indonesia Halal Requirements for Medical Devices: What Manufacturers and Importers Need to Know

Learn which products are covered by Indonesia's halal framework, the labeling and manufacturing obligations, and phased compliance timelines.

May 20, 2026
Indonesia Halal Requirements for Medical Devices: What Manufacturers and Importers Need to Know
A healthcare worker in a white coat checks a seated patient’s blood pressure while another medical staff member in green scrubs stands nearby holding a clipboard in a bright clinic setting.

Medical Device Market Access for Thailand, Indonesia, and the Philippines

Cisema offers regulatory insight and market access strategy for medical devices in Thailand, Indonesia, and the Philippines.

May 15, 2026
Medical Device Market Access for Thailand, Indonesia, and the Philippines
Medical Device Market Access for Thailand, Indonesia, and the Philippines

Medical Device Registration in Indonesia: A Practical Guide for Foreign Manufacturers

Learn how to register medical devices in Indonesia, including Authorized Representative rules, classification, dossiers, timelines, and fees.

May 15, 2026
Medical Device Registration in Indonesia: A Practical Guide for Foreign Manufacturers
Three masked surgical staff in green operating room attire stand with folded arms beside a patient lying on an operating table, with medical monitors and X-ray images displayed in a dimly lit operating room.”

Entering China’s Intraocular Lens (IOL) Market: NMPA Registration Requirements for Foreign Manufacturers

Understand the pathway for intraocular lens (IOL) registration in China, including NMPA requirements and key compliance steps.

May 14, 2026
Entering China’s Intraocular Lens (IOL) Market: NMPA Registration Requirements for Foreign Manufacturers
A close-up of an eye with a transparent intraocular lens held by surgical tweezers positioned in front of the pupil, illustrating ophthalmic medical device use. The visual supports themes of regulatory compliance, product registration, and market access
Previous
Previous

Our Medical Device Consulting Services Across Asia-Pacific

In addition to Taiwan, Cisema supports IVD and device registration, regulatory representation, and quality inspection services in:

China

Hong Kong SAR

Singapore

Malaysia

Vietnam

Philippines

Indonesia

Thailand

Latest Insights

View More

MFDS Issues 2025 Korea Medical Device Regulatory Update Report

Summary of 2025 MFDS trends covering medical device approvals, import dynamics, and the shift toward AI and software-based regulation.

June 2, 2026
MFDS Issues 2025 Korea Medical Device Regulatory Update Report

China Proposes Sweeping New Rules for Drugs, Medical Devices, and Special Foods Advertising

China’s SAMR has released draft advertising review measures that would increase oversight of livestreaming and digital marketing while streamlining certain compliance requirements for regulated products.

June 1, 2026
China Proposes Sweeping New Rules for Drugs, Medical Devices, and Special Foods Advertising

Hong Kong Expands Medical Device Listing Scope for Injectable Dermal Fillers

The updated GN-00 guidance reduces classification uncertainty and creates clearer MDACS pathways for injectable dermal fillers in Hong Kong.

May 29, 2026
Hong Kong Expands Medical Device Listing Scope for Injectable Dermal Fillers
Stock photo of a Chinese woman seated in a modern medical aesthetics clinic just seconds before receiving dermal filler treatment

Malaysia MDA Updates Medical Device Definitions, Special Access, & Legacy Device Rules 

Malaysia’s MDA has issued major updates affecting medical device classification, special access exemptions, and management of obsolete and discontinued devices under the Medical Device Act 2012

May 27, 2026
Malaysia MDA Updates Medical Device Definitions, Special Access, & Legacy Device Rules 
Ultra-photorealistic stock photo of a modern patient monitoring device in active clinical use inside a contemporary Malaysian hospital room.

China Launches Trial Medical Device Vigilance Framework Across 17 Pilot Regions

New measures define vigilance management, inspections, PSURs, trend reporting, and reporting requirements in 17 pilot regions

May 20, 2026
China Launches Trial Medical Device Vigilance Framework Across 17 Pilot Regions

China Launches National AI Roadmap for Pharmaceuticals, Medical Devices, & Cosmetics Supervision

China’s NMPA released a AI roadmap for smarter supervision across drugs, medical devices, and cosmetics regulation, covering AI-supported review, inspections, traceability, risk monitoring, and digital governance through 2035.

May 15, 2026
China Launches National AI Roadmap for Pharmaceuticals, Medical Devices, & Cosmetics Supervision
A business professional sits at a conference table using a laptop displaying a glowing digital brain graphic with the text “AI.” The setting appears to be a modern office with large windows and blurred city buildings in the background.
Previous
Previous

Get in Touch with Our Medical Devices Team

And discover how we can support you in achieving approval for your medical device in Taiwan.

Request Proposal